The role of fibrosis in cardiomyopathies: An opportunity to develop novel biomarkers of disease activity

被引:6
作者
Angeli, Elisavet [1 ,2 ]
Jordan, Maria [3 ,4 ]
Otto, Mandy [3 ,4 ]
Stojanovic, Stevan D. [5 ,6 ]
Karsdal, Morten [2 ]
Bauersachs, Johann [5 ]
Thum, Thomas [3 ,4 ,6 ]
Fiedler, Jan [3 ,4 ]
Genovese, Federica [1 ]
机构
[1] Univ Copenhagen, Dept Biomed Sci, Copenhagen, Denmark
[2] Nordic Biosci A S, Herlev, Denmark
[3] Fraunhofer Inst Toxicol & Expt Med ITEM, Hannover, Germany
[4] Fraunhofer Cluster Excellence Immune Mediated Dis, Hannover, Germany
[5] Hannover Med Sch, Dept Cardiol & Angiol, Hannover, Germany
[6] Hannover Med Sch, Inst Mol & Translat Therapeut Strategies, Hannover, Germany
基金
欧洲研究理事会;
关键词
Cardiomyopathies; Fibrosis; Extracellular matrix; Biomarkers; MYOCARDIAL INTERSTITIAL FIBROSIS; VENTRICULAR NON-COMPACTION; EXTRACELLULAR-MATRIX; HEART-FAILURE; DILATED CARDIOMYOPATHY; MAGNETIC-RESONANCE; FIBROBLAST ACTIVATION; NONINVASIVE DETECTION; AORTIC-STENOSIS; ANGIOTENSIN-II;
D O I
10.1016/j.matbio.2024.02.008
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Cardiomyopathies encompass a spectrum of heart disorders with diverse causes and presentations. Fibrosis stands out as a shared hallmark among various cardiomyopathies, reflecting a common thread in their pathogenesis. This prevalent fibrotic response is intricately linked to the consequences of dysregulated extracellular matrix (ECM) remodeling, emphasizing its significance in the development and progression the disease. This review explores the ECM involvement in various cardiomyopathies and its impact on myocardial stiffness and fibrosis. Additionally, we discuss the potential of ECM fragments as early diagnosis, prognosis, and risk stratification. Biomarkers deriving from turnover of collagens and other ECM proteins hold promise in clinical applications. We outline current clinical management, future directions, and the potential for personalized ECMtargeted therapies with specific focus on microRNAs. In summary, this review examines the role of the fibrosis in cardiomyopathies, highlighting the potential of ECM -derived biomarkers in improving disease management with implications for precision medicine.
引用
收藏
页码:65 / 78
页数:14
相关论文
共 214 条
[1]   Novel biomarkers in chronic heart failure [J].
Ahmad, Tariq ;
Fiuzat, Mona ;
Felker, G. Michael ;
O'Connor, Christopher .
NATURE REVIEWS CARDIOLOGY, 2012, 9 (06) :347-359
[2]   MATRIX METALLOPROTEINASE-2 IS AN INTERSTITIAL COLLAGENASE - INHIBITOR-FREE ENZYME CATALYZES THE CLEAVAGE OF COLLAGEN FIBRILS AND SOLUBLE NATIVE TYPE-I COLLAGEN GENERATING THE SPECIFIC 3/4-LENGTH AND 1/4-LENGTH FRAGMENTS [J].
AIMES, RT ;
QUIGLEY, JP .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (11) :5872-5876
[3]  
Akademiekurse O., 2021, Clin. Res. Cardiol., V110, P1695, DOI [10.1007/s00392-021-01933-9, DOI 10.1007/S00392-021-01933-9]
[4]   THE STRUCTURE OF FIBRONECTIN AND ITS ROLE IN CELLULAR ADHESION [J].
AKIYAMA, SK ;
YAMADA, KM ;
HAYASHI, M .
JOURNAL OF SUPRAMOLECULAR STRUCTURE AND CELLULAR BIOCHEMISTRY, 1981, 16 (04) :345-358
[5]   Anti-inflammatory properties of the novel antitumor agent yondelis (Trabectedin): Inhibition of macrophage differentiation and cytokine production [J].
Allavena, P ;
Signorelli, M ;
Chieppa, M ;
Erba, E ;
Bianchi, G ;
Marchesi, F ;
Olimpio, CO ;
Bonardi, C ;
Garbi, A ;
Lissoni, A ;
de Brand, F ;
Jimeno, J ;
D'Incalci, M .
CANCER RESEARCH, 2005, 65 (07) :2964-2971
[6]   Angiotensin Converting Enzyme Inhibitors (ACEIs) Decrease the Progression of Cardiac Fibrosis in Rheumatic Heart Disease Through the Inhibition of IL-33/sST2 [J].
Ambari, Ade M. ;
Setianto, Budhi ;
Santoso, Anwar ;
Radi, Basuni ;
Dwiputra, Bambang ;
Susilowati, Eliana ;
Tulrahmi, Fadilla ;
Doevendans, Pieter A. ;
Cramer, Maarten J. .
FRONTIERS IN CARDIOVASCULAR MEDICINE, 2020, 7
[7]   Biomimetic cultivation of atrial tissue slices as novel platform for in-vitro atrial arrhythmia studies [J].
Amesz, Jorik H. ;
de Groot, Natasja M. S. ;
Langmuur, Sanne J. J. ;
el Azzouzi, Hamid ;
Tiggeloven, Vera P. C. ;
van Rooij, Manuela M. M. M. ;
Knops, P. ;
Bogers, Ad J. J. C. ;
Taverne, Yannick J. H. J. .
SCIENTIFIC REPORTS, 2023, 13 (01)
[8]   Living myocardial slices: Advancing arrhythmia research [J].
Amesz, Jorik H. ;
Zhang, Lu ;
Everts, Bian R. ;
De Groot, Natasja M. S. ;
Taverne, Yannick J. H. J. .
FRONTIERS IN PHYSIOLOGY, 2023, 14
[9]   2023 ESC Guidelines for the management of cardiomyopathies Developed by the task force on the management of cardiomyopathies of the European Society of Cardiology (ESC) [J].
Arbelo, Elena ;
Protonotarios, Alexandros ;
Gimeno, Juan R. ;
Arbustini, Eloisa ;
Barriales-Villa, Roberto ;
Basso, Cristina ;
Bezzina, Connie R. ;
Biagini, Elena ;
Blom, Nico A. ;
de Boer, Rudolf A. ;
De Winter, Tim ;
Elliott, Perry M. ;
Flather, Marcus ;
Garcia-Pavia, Pablo ;
Haugaa, Kristina H. ;
Ingles, Jodie ;
Jurcut, Ruxandra Oana ;
Klaassen, Sabine ;
Limongelli, Giuseppe ;
Loeys, Bart ;
Mogensen, Jens ;
Olivotto, Iacopo ;
Pantazis, Antonis ;
Sharma, Sanjay ;
Van Tintelen, J. Peter ;
Ware, James S. ;
Kaski, Juan Pablo .
EUROPEAN HEART JOURNAL, 2023, 44 (37) :3503-3626
[10]   Neurohormonal activation is associated with increased levels of plasma matrix metal loproteinase-2 in human heart failure [J].
Banfi, C ;
Cavalca, V ;
Veglia, F ;
Brioschi, M ;
Barcella, S ;
Mussoni, L ;
Boccotti, L ;
Tremoli, E ;
Biglioli, P ;
Agostoni, P .
EUROPEAN HEART JOURNAL, 2005, 26 (05) :481-488